Boothbay Fund Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,500
| Closed | -$1.39M | – | 1875 |
|
|
2025
Q1 | $1.39M | Sell |
10,500
-8,200
| -44% | -$1.02M | 0.04% | 525 |
|
|
2024
Q4 | $1.56M | Buy |
+18,700
| New | +$1.54M | 0.04% | 510 |
|
|
2024
Q2 | – | Sell |
-17,600
| Closed | -$1.22M | – | 1917 |
|
|
2024
Q1 | $1.22M | Buy |
+17,600
| New | +$1.21M | 0.02% | 689 |
|
|
2021
Q2 | – | Sell |
-90
| Closed | -$305K | – | 2172 |
|
|
2021
Q1 | $305K | Sell |
90
-15
| -14% | -$520 | 0.01% | 1182 |
|
|
2020
Q4 | $334K | Hold |
105
| – | – | 0.01% | 910 |
|
|
2020
Q3 | $269K | Buy |
+105
| New | +$2.4K | 0.02% | 842 |
|
|
2020
Q1 | – | Sell |
-1,505
| Closed | -$5.17M | – | 1108 |
|
|
2019
Q4 | $5.17M | Buy |
1,505
+753
| +100% | +$9.04K | 0.45% | 43 |
|
|
2019
Q3 | $562K | Sell |
752
-1,132
| -60% | -$10.9K | 0.05% | 433 |
|
|
2019
Q2 | $2.44M | Buy |
+1,884
| New | +$24.2K | 0.22% | 117 |
|
Other funds holding ITCI
KIM
HNB